MedPath

POLYACTIVA PTY LTD

POLYACTIVA PTY LTD logo
🇦🇺Australia
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

9

Active:1
Completed:4

Trial Phases

3 Phases

Phase 1:7
Phase 2:1
Not Applicable:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (9 trials with phase data)• Click on a phase to view related trials

Phase 1
7 (77.8%)
Not Applicable
1 (11.1%)
Phase 2
1 (11.1%)

Evaluate Efficacy and Safety of PA5108 Ocular Implants in Primary Open Angle Glaucoma or Ocular Hypertension

Phase 2
Recruiting
Conditions
Glaucoma, Open-Angle
Ocular Hypertension
Interventions
Combination Product: PA5108 Ocular Implant low dose
Combination Product: PA5108 Ocular Implant, high dose
First Posted Date
2025-05-09
Last Posted Date
2025-06-13
Lead Sponsor
PolyActiva Pty Ltd
Target Recruit Count
75
Registration Number
NCT06964191
Locations
🇺🇸

Eye Research Foundation, Newport Beach, California, United States

Evaluate Efficacy, Safety, Tolerability and Biodegradation of PA5346 Ocular Implant in Patients With Open-Angle Glaucoma or Ocular Hypertension

Phase 1
Recruiting
Conditions
Open Angle Glaucoma (OAG)
Ocular Hypertension (OH)
First Posted Date
2025-05-09
Last Posted Date
2025-06-11
Lead Sponsor
PolyActiva Pty Ltd
Target Recruit Count
12
Registration Number
NCT06964061
Locations
🇦🇺

Cataract & Eye Surgery Centre, Doncaster, Victoria, Australia

🇦🇺

Melbourne Eye Specialists, Melbourne, Victoria, Australia

A Study of Levofloxacin Ocular Implant in Patients Undergoing Routine Bilateral Cataract Surgery

Phase 1
Withdrawn
Conditions
Cataract
Interventions
First Posted Date
2022-07-01
Last Posted Date
2024-04-12
Lead Sponsor
PolyActiva Pty Ltd
Registration Number
NCT05441930
Locations
🇺🇸

Ophthalmology Associates, Saint Louis, Missouri, United States

🇺🇸

Carolina Cataract and Laser Centre, Ladson, South Carolina, United States

🇦🇺

Melbourne Eye Specialists, Fitzroy, Victoria, Australia

Study of a Latanoprost Ocular Implant for Treatment of Open Angle Glaucoma or Ocular Hypertension.

Phase 1
Completed
Conditions
Open Angle Glaucoma
Ocular Hypertension
Interventions
Drug: 100ng/day PA5346 Latanoprost FA SR Ocular Implant
First Posted Date
2022-04-19
Last Posted Date
2024-04-12
Lead Sponsor
PolyActiva Pty Ltd
Target Recruit Count
1
Registration Number
NCT05333419
Locations
🇳🇿

Capital Eye Specialists, Te Aro, Wellington, New Zealand

🇳🇿

Rotorua Eye Clinic, Rotorua, New Zealand

Levofloxacin Ocular Implant for Ocular Surgery

Phase 1
Completed
Conditions
Cataract
Interventions
First Posted Date
2020-12-23
Last Posted Date
2021-12-08
Lead Sponsor
PolyActiva Pty Ltd
Target Recruit Count
5
Registration Number
NCT04682288
Locations
🇺🇸

Ophthalmology Consultants Ltd, Saint Louis, Missouri, United States

🇺🇸

Carolina Cataract and Laser Centre, Ladson, South Carolina, United States

🇦🇺

Melbourne Eye Specialists, Fitzroy, Victoria, Australia

  • Prev
  • 1
  • 2
  • Next

News

No news found
© Copyright 2025. All Rights Reserved by MedPath